Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Study finds that postpartum depression is underdiagnosed in those reporting symptoms up to a year after giving birth, with Black and Asian individuals least likely to receive treatment.
Columbia psychologist Erin K. Engle discusses the signs that indicate the time is right to stop therapy and questions patients should ask themselves before moving on.
Mice engineered with a human gene for schizophrenia and exposed to lead during early life exhibited behaviors and structural changes in their brains consistent with schizophrenia.
New findings show that the more heart attack-induced PTSD symptoms a patient has, the worse their sleep likely was in the month following their heart attack.
CUMC's Dr. Eric Kandel (2000 Nobel Laureate) said the project may lead to an understanding of "who we are as human beings and how we function and how these terrible diseases arise, and what we might be able to do address them more effectively."
New evidence that chronic infection, known to be associated with vascular disease, is also associated with poorer performance on tests of mental ability.
CUMC's Karina Davidson and team report a cost-effective, patient-centered approach that relieves depression in heart attack survivors -- ultimately reducing medical risk.
More symptoms of depression and lower cognitive status are independently associated with a more rapid decline in the ability to handle tasks of everyday living, according to a study by CUMC researchers.
A clinical trial, led by CUMC's Dr. Karina Davidson, found that treating heart disease patients for symptoms of depression is effective and may provide long-term cost-savings.
The first evidence that selective activation of the dentate gyrus in the hippocampus can reduce anxiety without affecting learning - important therapeutic implications.